Skip to main content
TipRanks
Go Ultimate75% OFF

THC Therapeutics (THCT) Financial Statements

33 Followers

THC Therapeutics Financial Overview

THC Therapeutics's market cap is currently $8.79K. The company's EPS TTM is $-0.02; its P/E ratio is -0.02; THC Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jul 23Jul 22Jul 21Jul 20Jul 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.39K$ -12.33K$ -16.37K$ -20.11K$ -25.56K
Operating Income$ -493.91K$ -1.75M$ -939.98K$ -1.32M$ -26.69M
EBITDA$ -492.52K$ -1.73M$ -923.61K$ -1.37M$ -24.23M
Net Income$ -387.04K$ -1.52M$ -1.89M$ -1.93M$ -23.61M
Balance Sheet
Cash & Short-Term Investments$ 10.00$ 32.00$ 296.13K$ 43.24K$ 317.55K
Total Assets$ 12.99K$ 206.90K$ 480.07K$ 85.35K$ 520.02K
Total Debt$ 791.44K$ 801.03K$ 761.35K$ 430.04K$ 177.55K
Net Debt$ 791.43K$ 801.00K$ 465.22K$ 386.80K$ -140.00K
Total Liabilities$ 3.32M$ 3.32M$ 2.96M$ 1.86M$ 1.27M
Stockholders' Equity$ -3.31M$ -3.11M$ -2.48M$ -1.78M$ -749.41K
Cash Flow
Free Cash Flow$ -85.43K$ -418.92K$ -388.48K$ -587.93K$ -331.00K
Operating Cash Flow$ -85.43K$ -418.92K$ -388.48K$ -587.93K$ -329.80K
Investing Cash Flow$ 0.00$ 0.00$ -152.78K$ 0.00$ -1.20K
Financing Cash Flow$ 85.41K$ 122.82K$ 794.15K$ 313.62K$ 645.58K

Currency in USD

THC Therapeutics Earnings and Revenue History

-30M-20M-10M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017201820192020202120222023RevenueEarningsProfit Margin

THC Therapeutics Liabilities to Assets

02M4M6M0 %10000 %20000 %30000 %LiabilitiesLiabilities to Assets2017201820192020202120222023AssetsLiabilitiesLiabilities to Assets

THC Therapeutics Cash Flow

-750K-500K-250K0250K500K750K1M2017201820192020202120222023OperatingInvestingFinancing

THC Therapeutics Forecast EPS vs Actual EPS